Authors:
Zuniga, J
Vargas-Alarcon, G
Salgado, N
Flores, C
Martinez-Tripp, S
Miranda, A
Balbuena, A
Osnaya, N
Juarez, F
Granados, J
Reyes-Teran, G
Citation: J. Zuniga et al., Determinant genetic factors of resistance to HIV infection and control of AIDS progression: Implications about pathogenesis and therapeutic strategies for HIV eradication - Genetic factors in HIV infection, REV INV CLI, 52(3), 2000, pp. 284-295
Authors:
Ramirez-Amador, VA
Esquivel-Pedraza, L
Ponce-de-Leon, S
Reyes-Teran, G
Gonzalez-Guevara, M
Ponce-de-Leon, S
Sierra-Madero, JG
Citation: Va. Ramirez-amador et al., Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial, CLIN INF D, 28(4), 1999, pp. 892-894
Authors:
Locher, CP
Grant, RM
Collisson, EA
Reyes-Teran, G
Elbeik, T
Kahn, JO
Levy, JA
Citation: Cp. Locher et al., Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination, AIDS RES H, 15(18), 1999, pp. 1685-1689
Authors:
Mourich, DV
Lee, S
Reyes-Teran, G
Mackewicz, CE
Levy, JA
Citation: Dv. Mourich et al., Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease, AIDS RES H, 15(17), 1999, pp. 1573-1575